Clinical Trial

Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of the current study is to measure the effect of melatonin as adjunct therapy on oxidative stress, inflammatory markers and clinical outcome in type 2 diabetic patients with diabetic peripheral neuropathy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-17; most recent amendment 2026-07-20.
Status change: Not Yet Recruiting → Recruiting 2025-08-05
Trial Details
NCT Number NCT07036796
Lead Sponsor Ain Shams University
Conditions Diabetic Peripheral Neuropathy, Diabetic Neuropathy, Diabetic Peripheral Neuropathy in Type 2 Diabetic Patients
Enrollment 60 participants
Start Date 2025-07-04
Primary Completion 2027-07-04 (estimated)
Study Completion 2027-07-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-21